SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is drawing attention after a strong quarterly report and rapid growth in its AI-compute business prompted bullish reactions and analyst upgrades. Traders are weighing that growth against heavy capital spending and an upcoming share unlock, while a possible Tesla merger remains speculative.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs earnings update drew attention as a softer revenue outlook and reduced advertising forecast overshadowed a profit beat, prompting a sharp selloff. Traders are split between concerns about slowing growth, ad execution and competition, and views that the reaction is excessive given the companys continued profitability.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS is drawing attention as traders position around the anticipated 80th-event milestone and final survival analysis for its Phase 3 REGAL trial of GPS in AML; the companys last disclosed count was 78 events. Bulls interpret the extended wait as potentially encouraging and speculate about a squeeze or buyout, while skeptics stress that neither the milestone nor favorable results have been confirmed.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micros preliminary quarterly outlook raised revenue and gross-margin expectations on strong AI-server demand, prompting a sharp rally. Many traders see a potential valuation re-rating or short squeeze, while others question whether margins, cash flow and execution can sustain the improvement.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

SpaceXs planned acquisition of low-band spectrum to expand Starlink Mobile has driven concerns about future competition, weighing on AT&T alongside other major carriers. Traders are split between seeing a lasting threat to wireless pricing and viewing the selloff as an overreaction given the years of investment and infrastructure needed to compete; many are buying the dip for AT&Ts fiber business and dividend.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabets weak, range-bound trading and upcoming earnings are focusing attention on whether cloud and AI growth can justify heavy infrastructure spending. Traders are split between viewing the pullback as a buying opportunity and worrying about capex, competition, and poor price action; quantum-computing news also draws interest but has not clearly shifted the debate.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokias AI-RAN push with NVIDIA and T-Mobileincluding a reported live-network call and plans for commercial trialsis driving interest in its potential role in AI and data-center infrastructure. Traders are upbeat about the strategic validation but debate whether these developments can translate into revenue and profits, particularly ahead of the Q3 report, while pointing to the stocks weak price action.

Zoom Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA.

Zoom Communications Inc. - Ordinary Shares - Class A

Oppenheimers upgrade of Zoom to Outperform is drawing attention, with traders pointing to AI-platform adoption and Zooms evolution beyond video meetings as reasons for optimism. Some remain skeptical that the AI opportunity will translate into stronger growth.

Amkor Technology, Inc. engages in the provision of outsourced semiconductor packaging and test services. Its services include design, package characterization, test, and wafer bumping services. The company was founded in 1968 and is headquartered in Tempe, AZ.

AMKOR Technology Inc.

Attention centers on Amkors upcoming quarterly report and whether AI-driven advanced-packaging demand can support growth, alongside planned capacity expansion and Nvidia-related business. Traders are divided: some see a long-term AI supply-chain opportunity, while others are frustrated by the stocks weakness and wary of earnings or guidance risk.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgicals strong Q3 results were overshadowed by a narrower da Vinci procedure-growth outlook, pricing pressure, and an antitrust settlement charge, triggering a sharp post-earnings selloff. Traders are split between calling the drop an overreaction and buying the dip, and viewing it as a repricing of slower growth expectations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Post Holdings' Pet E-Commerce Growth Outpaces Brick-and-Mortar

POST is seeing e-commerce outpace other pet food channels as it pursues brand relaunches, premium private-label growth and cost savings.

SJM vs. CELH: Which Stock Should Value Investors Buy Now?

SJM vs. CELH: Which Stock Is the Better Value Option?

Can J.M. Smucker's Hostess Donettes Drive a Broader Recovery?

J.M. Smucker's Donettes posts double-digit U.S. retail growth, but a 7% drop in Sweet Baked Snacks sales highlights the challenges ahead of a broader recovery.


Earnings Growth & Price Strength Make Smucker (SJM) a Stock to Watch

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

Why Smucker (SJM) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Buy 5 High-Flying Consumer Staples Stocks for a Stable Portfolio in Q4

CO, MO, LW, SJM and ELF have delivered over 20% YTD returns, backed by growth strategies and favorable earnings trends.


BGS Advances Portfolio Reshaping With Latest Brand Divestiture

BGS sells its B&M and Joan of Arc brands to cut debt, building on portfolio restructuring that lifted adjusted EBITDA and margins despite declining sales.


Can J.M. Smucker's Uncrustables Momentum Accelerate Further?

J.M. Smucker's Uncrustables gains momentum through strong consumer demand, product innovation and wider distribution, with added capacity supporting future growth.


Here's Why Smucker (SJM) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why Smucker (SJM) is a Strong Growth Stock

The J. M. Smucker Co. engages in the manufacture and marketing of food and beverage products. It operates through the following segments: U.S. Retail Coffee, U.S. Retail Frozen Handheld and Spreads, U.S. Retail Pet Foods, and Sweet Baked Snacks. The U.S. Retail Coffee segment includes the domestic sales of Folgers, Dunkin’, and Café Bustelo branded coffee. The U.S. Retail Frozen Handheld and Spreads segment focuses on domestic sales of Smucker’s and Jif branded products. The U.S. Retail Pet Foods segment is involved in the domestic sales of Meow Mix, Milk-Bone, Pup-Peroni, and Canine Carry Outs branded products. The Sweet Baked Snacks segment refers to all domestic and foreign sales of Hostess and Voortman branded products in all channels. The company was founded by Jerome Monroe Smucker in 1897 and is headquartered in Orrville, OH.

J.M. Smucker Co.

Why Did SJM, REPL, NEO Stocks Surge To 52-Week Highs Today? 

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>J.M. Smucker climbed to nearly a three-year high of $134.85 after the company posted better-than-expected fiscal 2027 first-quarter results.&nbsp;</li><li>JPMorgan kept an ‘Overweight’ rating on Replimune and raised its price target to $21 from $20.&nbsp;</li><li>NeoGenomics secured expanded Medicare coverage for its RaDaR ST liquid biopsy test.&nbsp;</li></ul><p>J.M. Smucker Co. (SJM), Replimune Group (REPL) and NeoGenomics (NEO) hit fresh 52-week highs on Wednesday, fueled by company-specific catalysts. Improving volumes at Smucker, clinical momentum at Replimune and Medicare coverage for NeoGenomics’ cancer test gave investors fresh reasons to buy.&nbsp;</p><p>J.M. Smucker and NeoGenomics stocks gained over 4% and 3%, while Replimune stock climbed 0.5%.&nbsp;</p><h2 class="st-heading-2">J.M.&nbsp;Smucker Gains On Improving Volumes</h2><p><a href="https://stocktwits.com/symbol/SJM">J.M. Smucker stock</a> reached nearly a three-year high of $134.85 after the packaged-food company delivered stronger-than-expected first-quarter fiscal 2027 results. The performance prompted BTIG to increase its price target to $150 from $130 while keeping a ‘Buy’ rating.</p><p>The key signal for investors was a recovery in underlying product volumes. With Hostess excluded, each of Smucker’s operating businesses posted volume gains during the quarter. The company’s Q2 revenue of $2.2 billion and earnings of $3.24 both exceeded analysts' consensus expectations of $2.1 billion and $2.2 per share, respectively, according to Fiscal Ai data.&nbsp;</p><p>On Stocktwits, retail sentiment around the stock remained in ‘bullish’ territory.&nbsp;</p><h2 class="st-heading-2">Replimune Builds On Clinical Momentum</h2><p><a href="https://stocktwits.com/symbol/REPL">Replimune stock</a> climbed to an annual high of $15.99 as investors continued to respond to developments surrounding its cancer-treatment pipeline. JPMorgan raised its price target to $21 from $20 and maintained an ‘Overweight’ rating.</p><p>The firm pointed to support from key opinion leaders for the company’s approach to treating melanoma patients whose disease has stopped responding to PD-1 therapies. Replimune’s Tudriqev program has emerged as an important part of that opportunity as the company advances through major regulatory approvals.</p><p>Retail sentiment around the stock remained in ‘bullish’ territory.&nbsp;</p><h2 class="st-heading-2">NeoGenomics Gets A Reimbursement Boost</h2><p><a href="https://stocktwits.com/symbol/NEO">NeoGenomics stock</a> also reached a new 52-week high of $17.45. The company received a Medicare coverage determination for its RaDaR ST liquid biopsy test, which is designed to help detect minimal residual disease and assess treatment response.</p><p>Medicare reimbursement could make it easier for physicians to include the test in cancer care. The decision could expand NeoGenomics' commercial opportunity by reducing a major hurdle to wider adoption by oncology practices. However, retail sentiment around the stock remained in ‘bearish’ territory.</p><p>So far this year, SJM, REPL and NEO stocks have gained between 33% and 63%.&nbsp;</p><p>Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/anf-stock-is-on-fire-after-strong-q2-why-jefferies-still-sees-18-more-upside/cZY8mnGRJpO">ANF Stock Is On Fire After ‘Strong Q2’ — Why Jefferies Still Sees 18% More Upside</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com</i></p>

In this photo illustration, a hand holds a smartphone displaying the logo of The J.M. Smucker Company.

Earnings, drug development, and healthcare reimbursement fueled the stock rallies.

Why Did SJM, REPL, NEO Stocks Surge To 52-Week Highs Today?

Earnings, drug development, and healthcare reimbursement fueled the stock rallies. 

Neogenomics Inc.

Replimune Group Inc

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

$SJM: the ask in Mercado is your money back. The Smucker hot fudge suit seeks the purchase price or the price difference, plus restitution, under NY consumer law. Filed May 14, no ruling, nothing to claim. Open Class Actions.

Clam Clamwell

$SJM Our read was bullish as of 13 Oct 2026, with an average conviction of 3.29 out of 5, supported by the chart attached. Trailing revenue grew 5.1% year-on-year to $9.2B, gross margin reached 39.2% aided by about $115.0M in tariff refunds, and fiscal 2026 free cash flow generated $1.2B to support debt reduction. The forward P/E sits at an attractive 11.1x based on raised fiscal 2027 adjusted EPS guidance of $10.50 to $11.00. Technically, the stock trades well above the 200-day moving average of $109.19 following a pullback from the $135.89 52-week high, while the RSI reads 49.1 and short interest eased to 4.1% of float. We would turn bearish if green coffee bean input costs trigger margin compression that overwhelms pricing power, or if funded net debt of $6.7B impedes capital allocation. (Disclosure: we're @astuteoptics1 and this is our own research.)

Astute Optics

$SJM: front label vs back panel is the whole Mercado fight. It alleges 'Sweetened with Splenda' implies sucralose does the work, while sugar alcohols lead the ingredient list. NY consumer law case, nothing to claim. Open Class Actions.

$SJM case watch: Mercado v. Smucker, 1:26-cv-04012, tests whether 'Sweetened with Splenda' misleads a reasonable shopper when sucralose is listed last. Smucker has not answered on the merits. Nothing to claim. Open Class Actions.

Feed

News

Sentiment

Earnings

Fundamentals

Info

SJM J.M. Smucker Co.

Fundamentals

Latest SJM News